The MHRA’s new resources are intended to help individuals make better-informed decisions about the digital mental health ...

Agency updates guidance after increase in reports of condition to its yellow card scheme ...

New online resources will help the public, parents, carers and health, social care and education professionals understand what safe, effective digital ...

Access to first-in-class medicinal products that can save and transform lives is crucial for patients in the UK – and the earlier the access, the more significant the impact. Equally vital, however, ...

The overall aim of the MHRA's proposals are to reduce duplicative costs for device manufacturers and hasten market access. Image credit: Dave Hoeek via Shutterstock.com. · Medical Device Network · ...

A new system for authorising medicines has been launched by the Medicines and Healthcare products Regulatory Agency (MHRA) to help bring new medicines to UK patients. At the time of the UK’s exit from ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first low-carbon version of a triple-combination inhaler for chronic obstructive pulmonary disease (COPD). The ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a call for evidence on artificial intelligence (AI) regulation in the NHS. The input will inform the work of the recently ...

The UK Government agency has issued new guidance on the use of digital tools for mental health and well-being concerns ...

Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed. Haemophilia A is an inherited bleeding disorder caused by a ...